Incidence of Venous Thromboembolism, Risk Factors and Prophylaxis in Hospitalized Patients in the South West Region of Cameroon
Authors Nkoke C, Tchinde Ngueping MJ, Atemkeng F, Teuwafeu D, Boombhi J, Menanga A
Received 19 February 2019
Accepted for publication 13 June 2019
Published 22 July 2020 Volume 2020:16 Pages 317—324
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Pietro Scicchitano
Clovis Nkoke,1 Marius Jordan Tchinde Ngueping,2 Faustin Atemkeng,3 Denis Teuwafeu,2 Jerome Boombhi,4 Alain Menanga4
1Buea Regional Hospital, Department of Internal Medicine, Buea, South West Region, Cameroon; 2University of Buea, Faculty of Health Sciences, Department of Medicine, Buea, South West Region, Cameroon; 3Deido District Hospital, Department of Surgery, Douala, Littoral Region, Cameroon; 4University of Yaounde I, Faculty of Medicine and Biomedical Sciences, Department of Internal Medicine, Yaounde, Center Region, Cameroon
Correspondence: Clovis Nkoke
Buea Regional Hospital, Department of Internal Medicine, Buea, South West Region, Cameroon
Tel +237 677970131
Background: Venous thromboembolism (VTE) is a serious complication in hospitalized patients. It is associated with considerable morbidity and mortality. Therefore, its prevention is of great importance. There is paucity of data on the incidence of VTE in hospitalized patients in Cameroon. The aim of this study was to determine the incidence of symptomatic VTE, its risk factors and the proportion of patients at risk that receive thromboprophylaxis in patients hospitalized in the medical and surgical units in two hospitals in the South West Region of Cameroon.
Methods: A prospective study was performed in the medical and surgical units from January to March 2018. All consecutive eligible patients admitted for at least 3 days were included. Patient profile and risk factors were recorded. Patients were followed and evaluated for signs and symptoms of VTE until discharge from hospital. Suspected VTE was confirmed using compression ultrasonography and computed tomography.
Results: A total of 314 patients were included of which 58.7% were females. The mean age was 46± 17.9 years. Patients aged < 40 years represented 42% of the study population. Three cases of symptomatic VTE were recorded. The incidence of symptomatic VTE was 1% (95% CI: 0.3– 2.8%). The prevalence of VTE risk was 93.6% with 32.5% being at high risk. The risk was 94.6% in medical patients and 92.8% in surgical patients. Among the patients at risk, only 32.5% received thromboprophylaxis. Thromboprophylaxis was significantly higher in surgical patients compared to medical patients (45.2% versus 18.7%; p< 0.0001).
Conclusion: The incidence of VTE in hospitalized medical and surgical patients appeared low but likely underestimated considering the high prevalence of patients at risk of VTE coupled with the underutilization of thromboprophylaxis. Clinicians should assess risk of VTE in conjunction with the clinical situation to determine the most appropriate type of prophylaxis as well as the duration of prophylaxis for VTE.
Keywords: venous thromboembolism, incidence, risk factors, prophylaxis, Cameroon
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]